characterised by excessive fibrotic tissue deposition in the pulmonary parenchyma. The term "pulmonary" refers to the lungs, while "fibrosis" denotes pathological scarring. The disease disrupts ...

characterized by excessive fibrotic tissue deposition in the pulmonary parenchyma. The term "pulmonary" refers to the lungs, while "fibrosis" denotes pathological scarring. The disease disrupts ...

Treatment practices in the U.S. show approximately 75% of diagnosed pulmonary sarcoidosis patients require treatment with ...

However, there is no available information in the literature regarding the prevalence of vitamin D deficiency among patients with diffuse parenchymal lung disease or whether reduced levels are ...

Dr Khan notes that between 10-30 minutes after vaping, one may experience feelings of "jitteriness or anxiety", but heart ...

Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis on track for the third quarter of 2025.

For instance, a sentence like: "The complex pathology of this condition involves emphysematous destruction of lung parenchyma, diffuse interstitial fibrosis, changes in the composition of lung ...

In this paper, we introduce the method of wavelet dynamic analysis to extract and repair the lung parenchyma, so as to exclude the noise interference outside the lung parenchyma. The algorithm can ...

an additional method is needed to prevent this exclusion and get the nodule included within lung parenchyma. There are two known methods for addressing the juxta-pleural nodule to be included in lung ...

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered in a new study in mice and humans by researchers at UCL ...

Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a dendritic-cell–natural-killer-cell circuit that suppresses leptomeningeal metastases in mouse ...